TriSalus Life Sciences, Inc.
TLSIW- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
In the last 90 days, TriSalus Life Sciences, Inc. insiders filed 1 open-market purchase and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $798.0K in total; no superinvestor holds it.
Other share classesTLSI
Holders of 5% or more of TLSIW
Holders whose latest Schedule 13D or 13G filing reports 5% or more of TriSalus Life Sciences, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of TriSalus Life Sciences, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on TriSalus Life Sciences, Inc., newest first.
No Schedule 13D or 13G filings on TriSalus Life Sciences, Inc. are on file.
Form 144: proposed insider sales
1 notice from officers, directors and other affiliates planning to sell TriSalus Life Sciences, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Dec 10, 20244:06 PM ET | Arjun DesaiBoard of Directors | 30.0K | $135.0K | Dec 10, 2024 | UBS Financial Services Inc | SEC |